News

US FDA advisers recommend against Otsuka's PTSD combination treatment
The U.S. Food and Drug Administration's panel of independent advisers on Friday voted against the efficacy of Otsuka Pharma's ...
FDA to Ask Sarepta to Halt Elevidys Shipments After Deaths
The Food and Drug Administration plans to ask Sarepta Therapeutics Inc. to pause shipments of its Elevidys treatment after ...
FDA Issues Highest Risk Warning For Dubai Chocolate Recall
The Food and Drug Administration has updated their recall of a batch of Dubai chocolate spread to Class I, their highest ...
FDA recalls frozen sprouted beans produced by Sugarland company for links to salmonella outbreak
Health officials have recalled two products produced by Chenak LLC, which has a location in Sugarland, for ties to a ...
MedPage Today1h
Remove Boxed Warning on Hormone Therapy for Menopause, FDA Panel Says
A panel selected by FDA Commissioner Marty Makary, MD, MPH, unanimously urged the agency to remove the boxed warning on ...
FDA makes Juul’s reign official
The FDA authorized Juul’s applications on Thursday to sell e-cigarettes in the U.S., determining they’re “appropriate for the ...
Exclusive-US FDA to Ask Sarepta to Stop Shipments of Gene Therapy Elevidys, Source Says
The agency's scrutiny of Sarepta has sharpened since the deaths of two teenage boys earlier this year who had received ...
FDA Issues Risk Warning for Ice Cream Recalled in 23 States
Rich Ice Cream Co. recalled numerous lots of its products on June 27 over potential contamination with Listeria monocytogenes ...
FDA Approves Juul E-Cigs for Sale, Years After Ban Attempt
FRIDAY, July 18, 2025 (HealthDay News) — After years of legal battles and health concerns, Juul Labs has the go-ahead to sell ...
FDA recalls over 67,000 cases of Power Stick deodorant. See where products were sold
The manufacturer announced a recall of 67,214 cases of its Power Stick roll-on deodorant due to violations of Current Good ...
US FDA advisers vote against Otsuka's PTSD combination treatment
The U.S. Food and Drug Administration's panel of independent advisers on Friday voted against the efficacy of Otsuka Pharma's ...